Abstract
During the COVID-19 outbreak, a number of patients with mental disorders were infected with 2019-nCoV, therefore, need to be treated with antivirals and antipsychiatric drugs at the same time. The long-term use of large doses of antivirals may lead to mental symptoms in patients infected with COVID-19, which require adjunctive antipsychiatric treatment to control mental symptoms. There is an interaction between antivirals and commonly used antipsychiatric drugs. In the current review, both Chinese and International databases were searched, the interaction between antivirals and antipsychiatric drugs were symmetrically introduced, as recommended for the treatment of COVID-19. We aim to provide theoretical basis and literature reference for front-line health professionals. Key words: Antiviral agents; Antipsychotic agents; Drug interactions; COVID-19; 2019-nCoV
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
